Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Daiichi Sankyo Enters \88 Bil. Market for NSAID Tapes with Loxonin
July 21, 2008
- Kyowa Hakko Starts Developing siRNA Drugs in Earnest
July 21, 2008
- MEDICAL DEVICE NEWS IN BRIEF
July 21, 2008
- REGULATORY NEWS IN BRIEF
July 21, 2008
- Korosho Takes into Account US Opposition to More Frequent Drug Price Revisions
July 21, 2008
- Use of Tamiflu Not Correlated with Abnormal Behavior: Korosho Working Group
July 21, 2008
- Chuikyo to Conduct Survey to Verify Effects of FY2008 Medical Fee Revision
July 21, 2008
- Switch OTC Drugs Hold Key to Market Revitalization
July 21, 2008
- FPAMJ's Proposal Meets Harsh Opposition at Chuikyo
July 21, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 21, 2008
- Industry Needs to Present More Data on Reform Proposed by It
July 21, 2008
- Korosho's Draft Report Sits on the Fence Re Qualification of Store Managers
July 21, 2008
- NEW PRODUCTS／Daiichi Sankyo, Lead Chemical: Loxonin Tape
July 21, 2008
- Armala May Outperform Sutent: ASCO 2008 Key Highlight Seminar
July 14, 2008
- Pfizer's Research Center Split Off to Create RaQualia
July 14, 2008
- 2008 Innovative DDS
July 14, 2008
- Prefilled Syringes Launched for Enbrel
July 14, 2008
- R&D NEWS IN BRIEF
July 14, 2008
- Takeda Completes US Business Consolidation by Merging TAP
July 14, 2008
- Takeda Files NDA for Panitumumab
July 14, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…